Balyasny Asset Management
ONEM

Balyasny Asset Management’s 1Life Healthcare ONEM Stock Holding History

Balyasny Asset Management’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,318,923
Closed -$88.9M – 3390
2022
Q4 		$88.9M Buy
+5,318,923
New +$89.9M 0.24% 89
2022
Q3 		– Sell
-3,349,036
Closed -$52.6M – 3407
2022
Q2 		$26.3M Buy
3,349,036
+1,276,724
+62% +$11M 0.09% 335
2022
Q1 		$23M Buy
2,072,312
+595,743
+40% +$6.67M 0.07% 370
2021
Q4 		$25.9M Buy
1,476,569
+723,333
+96% +$14M 0.09% 310
2021
Q3 		$15.3M Buy
+753,236
New +$19.4M 0.06% 416
2021
Q2 		– Sell
-92,383
Closed -$3.61M – 2527
2021
Q1 		$3.61M Buy
92,383
+83,608
+953% +$3.93M 0.02% 820
2020
Q4 		$383K Sell
8,775
-152,979
-95% -$5.23M ﹤0.01% 1159
2020
Q3 		$4.59M Buy
161,754
+101,083
+167% +$3.19M 0.03% 636
2020
Q2 		$2.2M Buy
+60,671
New +$1.71M 0.02% 703

Balyasny Asset Management's ONEM Position: Q1 2023 in Review

Balyasny Asset Management sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 5,318,923 shares — an estimated $88.9M sold.

Balyasny Asset Management first reported a position in ONEM in Q2 2020 and held it in 9 quarters. The position peaked at $88.9M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Balyasny Asset Management reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 5,318,923 1Life Healthcare shares in Q1 2023, an estimated $88.9M.
  • Balyasny Asset Management first reported a position in 1Life Healthcare in Q2 2020 and held it in 9 quarters.
  • Balyasny Asset Management's 1Life Healthcare position peaked at $88.9M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.